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Background: Patients with chronic obstructive pulmonary disease (COPD) are responsible
for a high utilisation of the health care resources, and the cost is expected to increase.
Physiological measures of lung function often fail to describe the impact the symptoms
have on exacerbations, days of hospitalisation, and on a patient’s health.
Methods: Twenty-one patients (14 female) with COPD (65 years, 40–79 years) admitted to
the Department of Respiratory Medicine in Uppsala, performed a pulmonary function test
(FEV1% predicted ¼ 37) and health status measurement (St. Georges Respiratory
Questionnaire, SGRQ) at discharge. Four to six weeks after discharge, when they were
in a stable clinical condition, they performed an exercise test (Incremental Shuttle Walk
Test, ISWT) to measure their exercise capacity.
Results: Nine of 21 patients (43%) were rehospitalised within 12 month. The mean
distance walked in the ISWTwas 174m in patients who were hospitalised and 358m in non-
hospitalised patients (Po0.001). Oxygen saturationp88% after the ISWTwas found in 73%
of hospitalised patients in contrast to only 22% in non-hospitalised patients (Po0.05).
Activity related health status (SGRQ-activity) was higher (worse) in hospitalised patients
than in non-hospitalised patients (75 vs. 50) (Po0.05). The association between walking
distance and the risk of rehospitalisation was significant after adjusting for oxygen
saturation and health status (hazard risk ratio 0.8 (0.67–0.97) per 10m).
This study has shown that walking distance is a good and reliable predictor of
rehospitalisations in moderately and severely disabled patients with COPD.
& 2006 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Chronic obstructive pulmonary disease (COPD) is a systemic
disease with airflow limitations, dyspnoea, peripheral
muscle dysfunction, exercise intolerance, malnutrition,
and exacerbations leading to hospitalisations.1
Exacerbations are associated with high health care costs,2
impaired quality of life,3 increased mortality,4 and increased
risk of readmission.5 Risk factors for morbidity and mortality
in COPD patients are under prescription of long term oxygen
therapy (LTOT),6 poor scores on quality of life question-
naires,3,7–10 patients with LTOT,9 long term steroid use,8
exposure to passive smoking,6 pulmonary hypertension,11
poor pulmonary function,5,6,9 and history of previous
admissions.5,6,9,10
Though it has been shown that there is a significant
relationship between functional exercise capacity (6-min
walk distance) and survival in COPD patients12 no data have
so far been reported whether there is a relationship
between exercise capacity and morbidity.
The objective was to assess the independent contribution
of exercise capacity (walking distance) to rehospitalisation
in COPD patients who had been admitted to hospital due to
an exacerbation.
Methods
Study design
This was a prospective study of patients with COPD
hospitalised with acute exacerbations of obstructive lung
disease.9,13,14 The study was approved by the ethical
committee, Uppsala University. Informed consent was
obtained from the patients.
Subjects
Consecutive patients that had been admitted with acute
exacerbation of obstructive lung disease performed an
exercise test 4–6 weeks after discharge.
Measurements
Spirometry, body mass index and smoking history: Predicted
values for forced expiratory volume in 1 s (FEV1) and forced
vital capacity (FVC) (Master scope, Jaeger, Germany) were
calculated based on the European Coal and Steel Union
reference values.15 Body mass index (BMI) was calculated as
weight (kg)/length (m)2. Information on smoking history was
collected by interview.
Health status was assessed using the disease-specific St.
George’s Respiratory Questionnaire (SGRQ).16
Exercise capacity was assessed using the Incremental
Shuttle Walk Test (ISWT).17 Before and after the test, heart
rate (HR), oxygen saturation (SpO2) (Pulse oximetry, Nonin
9500 Onxy, Nonin Medical Ino, Minneapolis), and Peak
Expiratory Flow (PEF) (Mini-Wright, Clement Clarke Inter-
national Ltd., UK) were measured.
Follow up: Enrolled patients were contacted by phone 1
year after discharge in order to obtain information regardingnumber of hospitalisations. These data were confirmed by
checking hospital records.
Statistics
The w2 test and an unpaired t-test were used when
comparing patients that had or had not performed the
ISWT, and had been hospitalised during the study period.
The time until readmission was analysed by the Kaplan–
Meier survival analysis and Cox regression. The Cox regres-
sion model included all variables that were significantly
related to hospitalisation in the univariate analysis as well as
sex and age. Linear regression was used to analyse the
relationship between ISWT and health status. A P-value of
o0.05 was considered statistically significant.
Results
ISWT and rehospitalisation
Of the 38 patients invited 21 (55%) accepted to participate
in the ISWT. No significant differences were found between
the participants and non-participants regarding age, gender
distribution, smoking, BMI or health related quality of life.
Nine of the 21 patients (43%) were rehospitalised within 12
months (Table 1). Patients that were rehospitalised during
the follow-up had a significantly shorter walking distance,
lower oxygen saturation (SpO2) before the ISWT and were
more likely to have a SpO2p88% after the ISWT. Patients
that had a rehospitalisation had a significantly lower activity
related health status (higher activity score).
The median walking distance in the ISWTwas 270m. Only
one hospitalisation was found among patients with a walking
distance above the median while 8 of the 11 patients with a
walking distance p270m were rehospitalised (Fig. 1). The
association between walking distance and the risk of
rehospitalisation remained statistically significant after
adjusting for oxygen saturation and health status (hazard
risk ratio 0.80 (0.67–0.97) per 10m).
ISWT and health related quality of life
Walking distance was the variable with the highest correla-
tion to activity and impact score, while SpO2 after the ISWT
was the variable that was most closely correlated to
symptoms and the total SGRQ score (Table 2).
The correlation between walking distance and FEV1 was
non-significant (r ¼ 0:40, P ¼ 0:06). FEV1 correlated signifi-
cantly to the activity score (r ¼ 0:41, P ¼ 0:049) but not to
any of the other health related quality of life scores.
Discussion
This study has shown that exercise capacity, measured as
Incremental Shuttle Walk Distance (ISWD), is an independent
predictor of rehospitalisation in patients with a moderate
and severe disease. Walking distance remained significant
after adjusting for the other variables that were associated
with the risk of rehospitalisation, i.e. resting oxygen
saturation, exercise desaturationo88%, and SGRQ activity
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Table 1 Personal characteristics, FEV1, health status, and results of the Incremental Shuttle Walk Test (ISWT) in patients
that did not and did have a rehospitalisation within the 12 month follow-up period (mean7SD and %).
No hospitalisation ðn ¼ 12Þ Hospitalisation ðn ¼ 9Þ P-value
Age (years) 65710 6579 0.90
Women 83 44 0.06
Pack years 33722 34723 0.91
FEV1 (% pred) 40712 32717 0.23
BMI (kg/m2) 2374 2274 0.64
Long term oxygen 8 33 0.15
SGRQ-activity 50727 75713 0.02
Walking distance (m) 358794 1747124 0.001
SpO2 before (%) 9572 9374 0.04
SpO2 afterp88% 22 73 0.02
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Figure 1 Proportion of patients with an exacerbation. The
patient group is divided according to the median walking
distance (270m).
Table 2 Correlation matrix of the association between
ISWT and health related quality of life (*Po0.05,
**Po0.01).
Symptoms Activity Impact Total
Walking distance 0.03 0.67** 0.53* 0.55*
SpO2 before 0.13 0.37 0.51* 0.46*
SpO2 after 0.52* 0.46* 0.50* 0.58**
DSpO2 0.53* 0.39 0.37 0.48*
DPEF 0.04 0.28 0.02 0.12
Predictor of exacerbations in COPD 1039score. We also found a high correlation between walking
distance and health related quality of life.
Although low levels of FEV1, by some investigators,
5,6,9
have been shown to be associated with hospitalisation for a
COPD exacerbation, our results suggest that exercise
capacity is a better marker of the risk of rehospitalisation.
Thus, FEV1 does not completely reflect the functional status
of moderate and severe COPD patients.18,19 Pinto-Plata and
coworkers studied severe COPD patients for 2 years and
found that the change in the distance walked per year was
significantly higher for non-survivors than for survivors,
whereas the change in FEV1 was in-significant. Thus, inpatients with a severe disease the decline in walking
distance can occur independently of the change in FEV1,
indicating that a walking test is valuable in the assessment
of COPD patients. The study is to small to define a threshold
value for walking distance but our results are in accordance
with a study in cardiac patients,20 who found that patients
with left ventricular dysfunction who walked less than 300m
had a significantly higher risk of being hospitalised or dying
compared with the group with the better performance.
In this study, patients that were rehospitalised during the
follow-up year had significantly lower resting oxygen
saturation and a greater proportion of the patients
desaturated below 88% during the walking test. Our results
are in line with results from Tojo and coworkers,21 who
found that PaO2 during maximal exercise was the best
predictor of patient survival followed by maximal oxygen
uptake.
There was a high correlation between walking distance
and health related quality of life (SGRQ, total score), and
the highest correlation was found between walking distance
and the activity score (r ¼ 0:67, Po0:01). This indicates
that physical capacity influences quality of life in patients
with COPD. Thus, physical training has a place in pulmonary
rehabilitation.
Our study had some limitations. First, the measurements
were not performed at the same time. The walking distance
was measured 4–6 weeks after discharge, when patients
were in a stable condition, while all other measurements
were performed at discharge. Second, the sample size was
small. Despite this, we were able to show a substantial and
significant difference in walking distance between the two
groups. If the sample size had been larger we might have
been able to find an independent association between
rehospitalisations and other variables such as oxygen
desaturation and health status. Despite the low sample size
of this study we think that the external validity is
acceptable, as there were no significant differences
between patients who wanted to participate and those
who refused.
The results of this study suggest that, in patients with a
moderate to severe COPD, exercise capacity (ISWT) adds
important independent information on the risk of rehospi-
talisations and health status to the routine evaluation of
patients with moderate to severe COPD. Although our
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M.I. Emtner et al.1040results should be confirmed in a larger study, our investiga-
tion indicates that measurement of exercise capacity should
be considered in the evaluation of these patients.
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